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Cloning confusion
 
very cloning pronouncement has one guaranteed ingredient: 
controversy. This time, Atsuo Ogura (National Institute 
of Infectious Diseases, Tokyo, Japan) and Rudolf Jaenisch 
(Massachusetts Institute of Technology, Cambridge, MA) are duking 
it out. Ogura claims that most of the defects that Jaenisch has seen 
in his cloned mice were caused by the genetic instability of the 
embryonic stem (ES) cells that Jaenisch used as a cloning source. 
In turn, Jaenisch calls Ogura’s claims of faithful gene expression 
“ludicrous” and “unbelievable.” Let the cloning wars continue.
At stake is an explanation 
of the various defects seen 
in some cloned offspring. 
Jaenisch believes that a 
number of things may be 
going wrong, but initially 
he has focused his attention 
on a subset of developmental 
genes called imprinted 
genes. Jaenisch found that a 
number of these genes were 
expressed at wildly varying 
levels in both his ES cells 
and the cloned progeny 
derived from these cells.
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Expression levels are variable in the 
placentas of cloned embryos.
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An imprinted gene is defined as one whose expression level 
varies depending on whether the gene was inherited from the 
father or mother. Jaenisch did not test parent-specific effects. 
But Ogura found that his clones expressed the correct allele 
of a number of imprinted genes: some were produced only 
from the paternal allele and others only from the maternal. 
Furthermore, a number of genes showed correct expression 
levels in cloned fetuses.
All is not sunny, however, even in Ogura’s world. The placentas 
of his cloned mice have variable and generally low expression of a 
wide range of genes, both imprinted and nonimprinted. Ogura 
believes that this is a general failure in reprogramming of gene 
expression, which might make it easier to tackle than the allele-
specific effects of imprinting. He is now using gene chip analysis to 
see if there is any pattern in the misexpression data, and to extend 
the current analysis. “We must know what is a cloning effect and 
what is a culture effect and what is a donor cell effect,” he says.
If cloning protocols are improved, deciding whether to allow 
human cloning will become that much more difficult. But for 
now, on this point, Ogura and Jaenisch agree. “If the scientific 
evidence changes we can change our views,” says Jaenisch. 
“Right now it is totally out of the question.”
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What makes Ran run?
 
hanges in the nucleotide state of 
Ran, a small GTPase, provide the 
energy that drives transport into the 
nucleus. But so many proteins affect 
Ran’s status or localization that is has 
been difficult to work out which, if 
any, are the key control points. Now, 
Alicia Smith and Ian Macara (University 
of Virginia, Charlottesville, VA) and 
colleagues have coupled real-time 
measurements of Ran transport with 
a computational model to come up 
with an answer.
“There’s been a lot of hype about 
computational biology, but it’s actually 
only useful to address certain types of 
questions,” says Macara. “This was a 
compartmental problem, so it was 
relatively easy to set up the model.” 
Macara did so with the help of Virtual 
Cell, a program developed by Leslie 
Loew and colleagues at the University of 
Connecticut Health Center, Farmington, 
CT. Macara plugged in a lot of rate 
constants, binding constants, and 
protein concentrations, many of which 
had been determined in earlier bio-
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chemical experiments. The resulting 
model matched the response of live 
cells when injected with labeled Ran, 
even when the levels of certain binding 
proteins and exchange factors were 
altered before injection.
There was little effect on the steady-
state transport kinetics after changing 
the levels or behaviors of a number of 
import factors. And yet the transport rate 
in vivo falls far short of the maximal 
rate seen in vitro, suggesting a control 
point. That control point may be Rcc1. 
This guanine nucleotide exchange 
factor converts recently imported 
RanGDP into RanGTP, thus triggering 
the discharge of Ran from its import 
carrier. The model showed that altering 
the levels of Rcc1 had the most 
profound effect on the rate of Ran 
transport. According to Macara, this 
kind of result “is something that’s 
very hard to determine in a system 
where everything is coupled to 
everything else.” Now that he has the 
working model, however, Macara can 
determine how accessory factors 
might alter import, and ask why the 
cell uses adapters as well as carriers 
during import.
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After injection, labeled Ran floods 
into the nucleus.
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